In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
Novo Nordisk’s Adiposity Franchise Under Siege as CVS Levels the Playing Field and US Pricing Rule
Novo Nordisk loses preferred CVS Caremark status for Wegovy as Eli Lilly gains parity; US pricing agreements squeeze…
Novo Nordisk’s Balancing Act: Weighing a Lost CVS Advantage Against a Make-or-Break Data Readout
CVS Caremark revokes Wegovy’s preferred status on formulary, opening door for Eli Lilly. Novo Nordisk shares fall 40%…
Novo Nordisk Faces a Two-Front Assault as CVS Drops Wegovy Exclusivity and Brazil Approves a Cheaper
CVS Caremark ends Wegovy’s exclusivity; Brazil approves Ozempic copycat. Novo faces mounting competition in US and emerging markets,…
Berlin police extradite suspect from Florida | News
BERLIN — The Berlin Police Department arrested a man for reportedly knocking a 71-year-old female to the ground…
Should You Forget CVS Health and Invest in a Purer Healthcare Play?
Key Points CVS Health has a far more diversified business than Novo Nordisk. Both approaches have perks and…